Systematic review finds serum biomarkers show variable diagnostic accuracy for oral cancer detection
This systematic review and meta-analysis evaluated the diagnostic accuracy of various serum biomarkers for oral squamous cell carcinoma (OSCC). The analysis included data from 3,309 subjects (2,069 with OSCC and 1,240 controls) and examined biomarkers including CYFRA 21-1, E-cadherin, interleukins (IL-6, IL-8), protein peaks, matrix metalloproteinases (MMP-9), vascular endothelial growth factor (VEGF), galectins (1, 3), and various RNA biomarkers compared to controls.
Diagnostic performance varied substantially across biomarkers. Overall sensitivity ranged from 16% to 94% and specificity from 37% to 100%. IL-8 demonstrated the highest accuracy with mean sensitivity of 86.5% and specificity of 98%. CYFRA 21-1 showed an area under the curve (AUC) of 0.53. Safety and tolerability data were not reported in the included studies.
Key limitations include moderate to high risk of bias in the included studies, which affects the reliability of the pooled estimates. Funding sources and conflicts of interest were not reported. The review suggests serum biomarkers have potential as adjunctive diagnostic tools that could complement histopathology and improve early detection, particularly in screening contexts. However, the substantial variability in performance and methodological limitations of the underlying evidence mean these findings should be interpreted cautiously in clinical practice.